Neuritis Clinical Trial
Official title:
Role of PRF With MTA and Theracal After Pulpotomy in Relieving Pain and Maintaining the Vitality of the Remaining Radicular Pulp Tissue in Permanent Posterior Teeth With Closed Root Apices: "Randomized Controlled Trial"
Verified date | August 2019 |
Source | Cairo University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
this research will evaluate the effect of PRF with different bioactive materials in dentistry
Status | Not yet recruiting |
Enrollment | 98 |
Est. completion date | September 30, 2019 |
Est. primary completion date | August 22, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 16 Years to 35 Years |
Eligibility |
Inclusion Criteria: - Patients suffering from Symptomatic pulpitis. - Patients should be free from any systemic disease that may affect normal healing and predictable outcome. - Patients who will agree to the consent and will commit to follow-up period. - Patients with mature root. - Patients with no periapical lesion. - Patients with localized pain. - Posterior teeth only will be involved Exclusion Criteria: - Patients with immature roots. - Patients with any systemic disease that may affect normal healing. - Patients with periapical lesions or infections. - Pregnant females. - Patients who could/would not participate in a 1-year follow-up. - Patients with fistula. - Patients with necrotic pulp. - Patients with old age. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | pain after the process | Questionnaire by asking the patient about the pain intensity | 1 year | |
Secondary | dentin bridge formation | X-ray | 1 year | |
Secondary | no periapical radiolucency | X-ray | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00772525 -
Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis
|
Phase 2 | |
Terminated |
NCT03247413 -
Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation
|
Phase 4 | |
Withdrawn |
NCT00037115 -
Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.
|
Phase 4 | |
Recruiting |
NCT05095844 -
National Vaccine Adverse Event Reporting Survey and Etiology
|
||
Recruiting |
NCT02107417 -
Study of TENS in Reducing Symptoms of Peripheral Neuropathy Induced by Chemotherapy
|
N/A | |
Recruiting |
NCT04448938 -
RESting-state Functional MRI in Patients With Optic Neuritis for ANticipation of reCovEry
|